(HealthDay)—As America rolls out a nationwide coronavirus vaccination campaign this week, experts help answer your questions about the new COVID-19 vaccines.
Dec 16, 2020
0
3
About five percent of patients experience heart muscle injury around the time of their surgery for a noncardiac condition, yet guideline recommendations to identify patients at risk using biomarkers are not being followed. ...
Dec 10, 2020
0
8
Healthcare professionals can estimate who is at most risk for dying from COVID-19, including seniors and those with a variety of health conditions. However, until recently, that estimate has mostly been based on judgment ...
Dec 7, 2020
0
3
The novel oral drug venetoclax can be safely added to standard therapies for some high-risk myeloid blood cancers and in early studies the combination shows promise of improved outcomes, say scientists from Dana-Farber Cancer ...
Dec 6, 2020
0
5
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels in nearly 80% of patients with advanced non-Hodgkin lymphoma (NHL) in a phase 2 clinical trial, Dana-Farber Cancer ...
Dec 5, 2020
0
187
Metabolites are small molecules found in our body's cells. They come from the food we eat, chemical processes happening within our bodies and microbes. A new analysis of recent studies has found that the levels of 10 metabolites ...
Dec 2, 2020
0
33
Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release.
Nov 26, 2020
0
3
A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
Nov 22, 2020
0
288
Preventing heart attacks and strokes in type 2 diabetes patients managed in primary care should be an urgent priority. That's the conclusion of a study published on World Diabetes Day in the European Journal of Preventive ...
Nov 14, 2020
0
7
COVID-19 (coronavirus) patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalization or emergency medical care than those who did not receive the antibody, according to ...
Oct 30, 2020
0
6
